Sacral neuromodulation; does it affect colonic transit time in patients with faecal incontinence?

Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
O UludagCor G Baeten

Abstract

Sacral neuromodulation (SNM) has been a successful treatment in urinary voiding disorders for years. A concomitant effect on bowel function was observed leading to the treatment of faecal incontinence with SNM. In this study we describe the effect of SNM on bowel frequency and (segmental) colonic transit time. Fourteen patients with faecal incontinence who qualified for permanent SNM underwent a colon transit study before and one month after permanent implant. Patients completed a three-week bowel habits diary before and during stimulation. Median incontinence episodes and days per week before SNM were, 8.7 and 4.2, respectively, and both decreased significantly to 0.67 (P = 0001) and 0.5 (P = 0001) during trial screening and to 0.33 (P = 0001) and 0.33 (P = 0001) after permanent implant. The median number of bowel movements per week decreased from 14.7 (6.7-41.7) to 10.0 (3.7-22.7)(P = 0005) during trial screening and to 10.0 (6.0-24.3)(P = 0008) during permanent stimulation. Resting and squeeze pressures did not change significantly during stimulation. Segmental colonic transit time before and during stimulation for right colon, left colon and recto sigmoid were, respectively, 6 (0-25) vs 5 (0-16) hours, 2 (0-29) vs 4 (0-45) ...Continue Reading

References

Jul 1, 1988·Gut·M A KammJ E Lennard-Jones
May 29, 1993·BMJ : British Medical Journal·C JenkinsonL Wright
Jun 1, 1996·Diseases of the Colon and Rectum·F AgachanS D Wexner
Mar 25, 2000·Diseases of the Colon and Rectum·C J VaizeyR J Nicholls
Jun 22, 2000·Annals of Surgery·A J MaloufM A Kamm
Jun 8, 2001·Diseases of the Colon and Rectum·A M LeroiP Denis
Aug 28, 2001·Gastroenterology·H R RosenR Schiessel
Feb 28, 2002·World Journal of Surgery·Andrew J MaloufMichael A Kamm
Jun 26, 2002·The British Journal of Surgery·N J KenefickM A Kamm
Jun 26, 2002·The British Journal of Surgery·N J KenefickM A Kamm
May 10, 2003·Applied Psychophysiology and Biofeedback·Jose Marcio N JorgeSteven D Wexner
Oct 16, 2004·Diseases of the Colon and Rectum·Ozenç UludağCor G M I Baeten
Jul 6, 2005·The British Journal of Surgery·O UludagC G M I Baeten

❮ Previous
Next ❯

Citations

Oct 16, 2009·Pediatric Surgery International·Andrea BischoffAlberto Peña
Sep 1, 2007·Clinical Obstetrics and Gynecology·Sarah E McAchran, Firouz Daneshgari
Nov 24, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·V VittonM Bouvier
Feb 10, 2011·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·C G M I Baeten
Feb 10, 2011·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·E V Carrington, C H Knowles
Oct 22, 2009·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·G NaldiniM Rossi
Jun 22, 2011·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·G GourcerolM Bouvier
Aug 30, 2014·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·E V CarringtonC H Knowles

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.